Hinge Health Reports 47% Revenue Growth to $182.3 Million in Latest Quarter

Hinge Health, Inc. reported significant financial growth in its latest quarterly filing for the three months ending March 31, 2026. The company achieved revenue of $182.3 million, marking a 47% increase from $123.8 million in the same period last year. This growth was primarily driven by increased revenue from existing clients, as the majority of new client contracts signed in 2025 will contribute to revenue recognition in the following year. The company also reported a net income of $35.1 million, compared to $17.1 million in the prior year, reflecting a substantial improvement in profitability.

The company's operating expenses rose to $122.2 million from $87.1 million year-over-year, largely due to increased investments in research and development, sales and marketing, and general administrative costs. Research and development expenses increased by 29% to $30.3 million, while sales and marketing expenses surged by 47% to $68.8 million. Despite these rising costs, Hinge Health's gross profit improved to $154.2 million, resulting in a gross margin of 85%, up from 81% in the previous year, indicating enhanced operational efficiency.

Hinge Health's operational metrics also showed positive trends, with the number of clients increasing to 2,849 from 2,311 year-over-year. The company reported a total of 782,890 members engaged with its platform, a significant increase from 532,326 in the prior year. The last twelve months (LTM) average eligible lives reached 20.1 million, up from 15.7 million, reflecting the company's expanding market presence. The company continues to focus on enhancing its platform and services, including the recent launch of HingeSelect, a high-performance provider network for musculoskeletal care.

In terms of cash flow, Hinge Health generated $43.1 million from operating activities, a notable increase from $4.9 million in the same quarter last year. The company also reported net cash provided by investing activities of $48.1 million, primarily from maturities of marketable securities. However, cash used in financing activities totaled $112.8 million, largely due to a share repurchase program that saw the company buy back $105 million of its Class A common stock.

Looking ahead, Hinge Health remains optimistic about its growth trajectory, emphasizing its commitment to innovation and expanding its client base. The company plans to continue leveraging its AI-driven platform to enhance member engagement and improve health outcomes while managing costs effectively. Hinge Health's strategic focus on diversifying its revenue streams and expanding into new markets positions it well for sustained growth in the evolving healthcare landscape.